These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38205778)

  • 1. Comparison of interaction between antimiR and microRNA versus HDO-antimiR and microRNA by molecular dynamics simulation.
    Nishina K; Yoshioka K; Yokota T; Hara RI
    Nucleosides Nucleotides Nucleic Acids; 2024 Jan; ():1-16. PubMed ID: 38205778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
    Yoshioka K; Kunieda T; Asami Y; Guo H; Miyata H; Yoshida-Tanaka K; Sujino Y; Piao W; Kuwahara H; Nishina K; Hara RI; Nagata T; Wada T; Obika S; Yokota T
    Nucleic Acids Res; 2019 Aug; 47(14):7321-7332. PubMed ID: 31214713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking.
    Ono D; Asada K; Yui D; Sakaue F; Yoshioka K; Nagata T; Yokota T
    Mol Ther Nucleic Acids; 2021 Mar; 23():1360-1370. PubMed ID: 33738132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice.
    Suzuki M; Ishibashi S; Iwasawa E; Oguma T; Saito Y; Li F; Otsu S; Ichinose K; Yoshioka K; Nagata T; Yokota T
    Sci Rep; 2021 Jul; 11(1):14237. PubMed ID: 34244578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
    Asada K; Sakaue F; Nagata T; Zhang JC; Yoshida-Tanaka K; Abe A; Nawa M; Nishina K; Yokota T
    Nucleic Acids Res; 2021 May; 49(9):4864-4876. PubMed ID: 33928345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Model Analysis and Simulation of Pharmacokinetics and
    Goto A; Yamamoto S; Igari T; Matsumoto SI; Chisaki I; Iida K; Nakayama M; Oda A; Kakoi Y; Uchida A; Miyata K; Nishikawa M; Nagata T; Kusuhara H; Yokota T; Hirabayashi H
    J Pharmacol Exp Ther; 2023 Jan; 384(1):197-204. PubMed ID: 36273821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells.
    Sousa de Almeida M; Rothen-Rutishauser B; Mayer M; Taskova M
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
    Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
    Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
    McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT
    J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of microRNA function by antimiR oligonucleotides.
    Stenvang J; Petri A; Lindow M; Obad S; Kauppinen S
    Silence; 2012 Jan; 3(1):1. PubMed ID: 22230293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
    Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
    J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides.
    Nishi R; Ohyagi M; Nagata T; Mabuchi Y; Yokota T
    Mol Ther; 2022 Jun; 30(6):2210-2223. PubMed ID: 35189344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a "Personalized" Anti-microRNA Therapy.
    Ananta JS; Paulmurugan R; Massoud TF
    Mol Pharm; 2016 Sep; 13(9):3164-75. PubMed ID: 27508339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs.
    Hara RI; Hisada Y; Maeda Y; Yokota T; Wada T
    Sci Rep; 2018 Mar; 8(1):4323. PubMed ID: 29531343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA inhibition using antimiRs in acute human brain tissue sections.
    Morris G; Langa E; Fearon C; Conboy K; Lau E-How K; Sanz-Rodriguez A; O'Brien DF; Sweeney K; Lacey A; Delanty N; Beausang A; Brett FM; Cryan JB; Cunningham MO; Henshall DC
    Epilepsia; 2022 Aug; 63(8):e92-e99. PubMed ID: 35656590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.